[Hypermetabolism syndrome in critically ill children]

Insights

This study explores hypermetabolism in children, highlighting how therapeutic feeding aids recovery and prevents organ dysfunction during critical illness. Artificial nutrition is key for restoring energy and building tissues in stressed pediatric patients.

Area of Science:

  • Pediatric critical care medicine
  • Developmental physiology
  • Metabolic disorders

Context:

  • Hypermetabolism presents unique challenges in pediatric critical care.
  • Understanding pathophysiological reactions in children is crucial for effective treatment.
  • Stress-induced metabolic changes require specialized interventions.

Purpose:

  • To elucidate the developmental mechanisms and triggers of hypermetabolism in children.
  • To describe the specific pathophysiological reactions in pediatric patients experiencing stress.
  • To evaluate the role of artificial therapeutic feeding in managing metabolic demands.

Summary:

  • The paper details the development and triggers of hypermetabolism in pediatric patients.
  • It outlines the specific pathophysiological responses observed in children.
  • Artificial therapeutic feeding is identified as a critical component of multimodal therapy.

Impact:

  • Artificial feeding is essential for restoring plastic and energy demands in stressed children.
  • Early implementation of therapeutic feeding can prevent multiple organ dysfunction.
  • This research informs strategies for optimizing nutritional support in critically ill children.

Related Concept Videos

Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
Overview of Protein Metabolism01:21

Overview of Protein Metabolism

Proteins are broken down into amino acids during digestion. Unlike fats and carbohydrates, which are stored for later use, proteins are not. Instead, amino acids are either used to produce ATP through oxidation or contribute to the creation of new proteins for the growth and repair of the body. Any surplus amino acids from the diet are converted into glucose or triglycerides rather than excreted.
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
What is Metabolism?00:52

What is Metabolism?

Overview
Diabetic Ketoacidosis ll: Pathophysiology01:22

Diabetic Ketoacidosis ll: Pathophysiology

Diabetic ketoacidosis (DKA) is a metabolic emergency characterized by hyperglycemia, ketonemia, and metabolic acidosis. It results from severe insulin deficiency and an excess of counterregulatory hormones, leading to uncontrolled lipolysis, ketogenesis, and widespread electrolyte and fluid disturbances.Pathophysiology The central event in DKA is a profound loss of insulin action. Without insulin, glucose uptake in insulin-dependent tissues is impaired, while hepatic glucose production...
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without causing...
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...